MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biomaterials (Polymer-based Biomaterials)
Ideal BioStent
Parents
*Architects: Biomaterials (Polymer-based Biomaterials)
*Architects: Surgical Technology_Cardiovascular, Cardiac & Cardiology Companies _ Stents
Xenogenics Corporation
Children
As the polymer degrades, salicylate is released directly into the vessel wall to provide anti-inflammatory therapy aimed at redu
MultiCell Technologies Inc. (MCET.OB)'s Majority Owned Subsidiary Xenogenics Acquires Bioabsorbable Interventional Cardiology St
Strong intellectual property portfolio covering the Ideal BioStent.
The Ideal BioStent is the only stent to offer a dual-drug polymer, incorporating salicylate, the active component in aspirin, di
This patent estate includes 24 issued patents, and over 65 patent applications with broad claims encompassing interventional car
Jumps
Rutgers University